IHI.org - A resource from the Institute for Healthcare Improvement
Header Image






Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome: The Phospholipase A2 Study Group
Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome: The Phospholipase A2 Study Group. The Clinical Investigator. 1994;72(10):782–787.

This study's findings suggest that low-dose hydrocortisone infusion can help combat a systemic inflammatory response in septic shock.



Rated by Users: User rating
Rate This Item

View article abstract